ArticleScientific reports2025
Structural and functional insights of ZnT1 C-terminal domain as a regulator of zinc transport.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Zinc is an essential trace element vital for cellular function, and its homeostasis is tightly regulated. ZnT1, a cation diffusion facilitator (CDF) family member, extrudes excess zinc across the mammalian plasma membrane, making it a major part of the zinc homeostasis system. While ZnT1 shares structural similarities with other CDF proteins, the role of its C-terminal domain (CTD) in zinc transport remains unclear. We used structural determination and comparative analysis, site-directed mutagenesis, and functional zinc transport assays to demonstrate that the ZnT1 CTD is a regulatory element. The regulation involves a distinct CTD conformational change upon structural, non-transported zinc binding. The observed conformational changes in the mammalian CTD are different from those observed in prokaryotic CDFs. The effects of mutating the CTD zinc-binding site on zinc transport are consistent with a hierarchical trend in the CTD regulatory role, possibly due to the importance of the CTD zinc-binding residues. This is in contrast to mutations designed to induce different prokaryotic CTD conformations that do not affect transport. Finally, we show that the unstructured extension of the CTD is dispensable, and its deletion does not affect zinc transport. Our findings establish the CTD as a key modulator of ZnT1 activity, revealing both conserved and divergent regulatory strategies across species. By elucidating ZnT1's transport regulation, this study advances our understanding of how structurally related transporters fine-tune zinc homeostasis across biological systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.